EdgarLookup

ABVC BIOPHARMA, INC. — 8-K Filings

250 8-K filings on record

This page lists all 8-K filings submitted to the SEC by ABVC BIOPHARMA, INC. (ABVC), sorted by most recent first. Each row links to the full filing on EdgarLookup. ABVC BIOPHARMA, INC. has filed 250 8-K documents with the SEC since 2002. To view all SEC filings by ABVC BIOPHARMA, INC., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-KT 10-Q 10-Q/A 10KSB 10KSB/A 10QSB 3 3/A 4 4/A 424B1 424B2 424B3 424B4 424B5 5 8-A12B 8-K 8-K/A AW CERT CORRESP D DEF 14A DEFA14A EFFECT NT 10-K NT 10-Q POS AM PRE 14A PREM14A RW S-1 S-1/A S-1MEF S-3 S-3/A S-4 S-4/A S-8 S-8 POS SB-2 SB-2/A SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001213900-26-035499 Mar 27, 2026
8-K CURRENT REPORT 0001213900-26-023054 Mar 3, 2026
8-K CURRENT REPORT 0001213900-25-104900 Nov 3, 2025
8-K CURRENT REPORT 0001213900-25-103799 Oct 30, 2025 Oct 28, 2025
8-K CURRENT REPORT 0001213900-25-076018 Aug 14, 2025
8-K CURRENT REPORT 0001213900-25-051144 Jun 4, 2025 Jun 3, 2025
8-K CURRENT REPORT 0001213900-25-038060 May 1, 2025
8-K CURRENT REPORT 0001213900-25-037654 Apr 30, 2025
8-K CURRENT REPORT 0001213900-25-032135 Apr 15, 2025
8-K CURRENT REPORT 0001213900-25-021713 Mar 7, 2025 Mar 5, 2025
8-K CURRENT REPORT 0001213900-25-001211 Jan 6, 2025
8-K CURRENT REPORT 0001213900-24-097894 Nov 14, 2024
8-K CURRENT REPORT 0001213900-24-094178 Nov 4, 2024
8-K CURRENT REPORT 0001213900-24-089013 Oct 18, 2024
8-K CURRENT REPORT 0001213900-24-077361 Sep 10, 2024
8-K CURRENT REPORT 0001213900-24-071145 Aug 20, 2024
8-K CURRENT REPORT 0001213900-24-069338 Aug 15, 2024
8-K CURRENT REPORT 0001213900-24-063627 Jul 23, 2024
8-K CURRENT REPORT 0001213900-24-061028 Jul 12, 2024
8-K CURRENT REPORT 0001213900-24-046419 May 24, 2024
8-K CURRENT REPORT 0001213900-24-046313 May 23, 2024
8-K CURRENT REPORT 0001213900-24-043229 May 15, 2024
8-K CURRENT REPORT 0001213900-24-041053 May 9, 2024
8-K FORM 8-K 0001213900-24-034583 Apr 19, 2024
8-K CURRENT REPORT 0001213900-24-033598 Apr 17, 2024
8-K CURRENT REPORT 0001213900-24-025793 Mar 26, 2024
8-K FORM 8-K 0001213900-24-022451 Mar 14, 2024
8-K CURRENT REPORT 0001213900-24-022396 Mar 14, 2024
8-K CURRENT REPORT 0001213900-24-011360 Feb 8, 2024
8-K CURRENT REPORT 0001213900-24-004172 Jan 17, 2024
8-K CURRENT REPORT 0001213900-24-004194 Jan 17, 2024 Jan 16, 2024
8-K CURRENT REPORT 0001213900-23-088524 Nov 20, 2023
8-K CURRENT REPORT 0001213900-23-087740 Nov 16, 2023
8-K CURRENT REPORT 0001213900-23-087289 Nov 15, 2023
8-K CURRENT REPORT 0001213900-23-076241 Sep 13, 2023
8-K CURRENT REPORT 0001213900-23-072608 Aug 31, 2023
8-K CURRENT REPORT 0001213900-23-068359 Aug 17, 2023 Aug 14, 2023
8-K CURRENT REPORT 0001213900-23-063832 Aug 7, 2023
8-K CURRENT REPORT 0001213900-23-062628 Aug 2, 2023
8-K CURRENT REPORT 0001213900-23-061038 Jul 31, 2023
8-K CURRENT REPORT 0001213900-23-060140 Jul 27, 2023
8-K CURRENT REPORT 0001213900-23-059044 Jul 24, 2023
8-K CURRENT REPORT 0001213900-23-055559 Jul 7, 2023
8-K CURRENT REPORT 0001213900-23-051347 Jun 23, 2023
8-K CURRENT REPORT 0001213900-23-049300 Jun 15, 2023
8-K CURRENT REPORT 0001213900-23-047871 Jun 9, 2023
8-K CURRENT REPORT 0001213900-23-047870 Jun 9, 2023
8-K CURRENT REPORT 0001213900-23-043545 May 26, 2023
8-K CURRENT REPORT 0001213900-23-031964 Apr 24, 2023
8-K CURRENT REPORT 0001213900-23-025564 Mar 31, 2023